1-3 of 3
Gary K. Schwartz
Close
Sort by
Journal Articles

A Phase I Study of IDH305 in Patients with Advanced Malignancies Including Relapsed/Refractory AML and MDS That Harbor IDH1 R132 Mutations

Courtney D DiNardo, MD, Aaron D. Schimmer, MD PhD, Karen W.L. Yee, MD, Andreas Hochhaus, MD, Alwin Kraemer, MD, Richard D. Carvajal, MD, Filip Janku, MD PhD, Philippe Bedard, MD, Cecilia Carpio, MD, Antje Wick, MD, Gary K. Schwartz, MD, Patrick Schöffski, MD, Patrick Wen, MD, Martin J. van den Bent, MD, Mark Rosenthal, MD PhD, Jessica O'Keeffe, BS, Xueying Chen, PhD, Raymond Pagliarini, PhD, Virna Schuck, PhD, Andrea Myers, MD PhD, Andrew Wei
Journal: Blood
Blood (2016) 128 (22): 1073.
https://doi.org/10.1182/blood.V128.22.1073.1073
Published: 2016
Journal Articles

ABT-888 Plus Bendamustine Is Safe and Has Shown Preliminary Efficacy In Patients With Lymphoma

John F. Gerecitano, MD, PhD, Gary K Schwartz, Richard Carvajal, MD, Matthew Fury, MD, PhD, Jason Konner, David M. Hyman, MD, Mrinal Gounder, Devika Gajria, Jerrold Teitcher, Zhigang Zhang, PhD, Craig H. Moskowitz, MD, Jan H Beumer, PharmD, PhD, Alice Chen, MD, Richard F Little, MPH, MD, Fallon France, Juho Whang, Jennifer Winkelman, Megan Stasi, Corey Russell, Naomi Cazeau, Katherine Kargus, Andrew D. Zelenetz, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4366.
https://doi.org/10.1182/blood.V122.21.4366.4366
Published: 2013
Journal Articles

The Novel Cyclin-Dependent Kinase Inhibitor Flavopiridol Downregulates Bcl-2 and Induces Growth Arrest and Apoptosis in Chronic B-Cell Leukemia Lines

Andrea König, Gary K. Schwartz, Ramzi M. Mohammad, Ayad Al-Katib, Janice L. Gabrilove
Journal: Blood
Blood (1997) 90 (11): 4307–4312.
https://doi.org/10.1182/blood.V90.11.4307
Published: 1997